Retropupillary fixated iris claw lens -an option for aphakia management

---

Original Article

Author Details : Sakshi Patil, Navneet Chhabda*

Volume : 5, Issue : 2, Year : 2019

Article Page : 76-79

https://doi.org/10.18231/j.ijooo.2019.020

Suggest article by email

Get Permission

---

Abstract

Aim: To study visual and surgical outcome in aphakic patients after implantation of retropupillary fixated iris claw lens.
Materials and Methods: Medical records of the patients operated in Bharati Hospital, Sangli for the treatment of aphakia by secondary retropupillary fixated iris claw lens from September 2017 to August 2018 were included in the study. The data collected included the preoperative best corrected visual acuity (BCVA), auto-refractokeratometry, anterior segment evaluation on the slit lamp and posterior segment evaluation done by indirect ophthalmoscopy after pupillary dilatation with tropicamide eyedrops. The patients were also assessed for lacrimal sac patency and Goldmann applantion tonometry for intraocular pressure (IOP). Intraocular lens (IOL) power was calculated by SRK-T formula in aphakic mode by immersion based biometry. At follow up i.e. day 7 and 1 month, findings of patients include in study were BCVA, slit lamp examination and auto-refractokeratometry.
Results: 86.66% patients operated by retropupillary fixated iris claw lens had postoperative improvement in visual acuity as compared to preoperative visual acuity.
Conclusions: Retropupillary fixated Iris claw lens is an effective method of aphakia management with good visual outcomes and easy learning curve.

Keywords: Aphakia, Iris claw lens, Visual acuity.

How to cite : Patil S, Chhabda N, Retropupillary fixated iris claw lens -an option for aphakia management. IP Int J Ocul Oncol Oculoplasty 2019;5(2):76-79

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.